MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas.
Tomohiro HosoyaMasamichi TakahashiMai Honda-KitaharaYasuji MiyakitaMakoto OhnoShunsuke YanagisawaTakaki OmuraDaisuke KawauchiYukie TamuraMiyu KikuchiTomoyuki NakanoAkihiko YoshidaHiroshi IgakiYuko MatsushitaKoichi IchimuraYoshitaka NaritaPublished in: Journal of neuro-oncology (2022)
Evaluation of MGMTpm% by pyrosequencing is important in predicting the volumetric response and prognosis of glioblastoma patients with residual tumors.